{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:31:04Z","timestamp":1786476664073,"version":"build-2736575974"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,11]]},"DOI":"10.7759\/cureus.114365","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:07:41Z","timestamp":1786475261000},"source":"Crossref","is-referenced-by-count":0,"title":["Influence of Vitamin D on the Growth and Development of Uterine Fibroids"],"prefix":"10.7759","author":[{"given":"Noura E","family":"Awad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Fibroids (uterine myomatosis, leiomyomas)","volume":"2015","author":"Lethaby A","year":"2015","unstructured":"Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). BMJ Clin Evid. 2015, 2015:0814.","journal-title":"BMJ Clin Evid"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani E","year":"2020","unstructured":"Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020, 149:1-9. 10.1002\/ijgo.13102","journal-title":"Int J Gynaecol Obstet"},{"key":"ref3","unstructured":"Uterine fibroids. (2025). https.\/\/www.msdmanuals.com\/professional\/gynecology-and-obstetrics\/uterine-fibroids\/uterine-fibroids."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2016.09.011","article-title":"Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years","volume":"40","author":"Munro MG","year":"2017","unstructured":"Munro MG. Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years. Best Pract Res Clin Obstet Gynaecol. 2017, 40:3-22. 10.1016\/j.bpobgyn.2016.09.011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4274\/jtgga.galenos.2021.2020.0228","article-title":"Abnormal uterine bleeding types according to the PALM-COEIN FIGO classification in a medically underserved American community","volume":"22","author":"Sabre A","year":"2021","unstructured":"Sabre A, Serventi L, Nuritdinova D, Schiattarella A, Sisti G. Abnormal uterine bleeding types according to the PALM-COEIN FIGO classification in a medically underserved American community. J Turk Ger Gynecol Assoc. 2021, 22:91-6. 10.4274\/jtgga.galenos.2021.2020.0228","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro MG","year":"2018","unstructured":"Munro MG, Critchley HO, Fraser IS. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018, 143:393-408. 10.1002\/ijgo.12666","journal-title":"Int J Gynaecol Obstet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2327","article-title":"High aromatase expression in uterine leiomyoma tissues of African-American women","volume":"94","author":"Ishikawa H","year":"2009","unstructured":"Ishikawa H, Reierstad S, Demura M, et al.. High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab. 2009, 94:1752-6. 10.1210\/jc.2008-2327","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-0224","article-title":"Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation","volume":"150","author":"Nierth-Simpson EN","year":"2009","unstructured":"Nierth-Simpson EN, Martin MM, Chiang TC, et al.. Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation. Endocrinology. 2009, 150:2436-45. 10.1210\/en.2008-0224","journal-title":"Endocrinology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(02)03366-6","article-title":"Coordinated regulation of HOX gene expression in myometrium and uterine leiomyoma","volume":"78","author":"Cermik D","year":"2002","unstructured":"Cermik D, Arici A, Taylor HS. Coordinated regulation of HOX gene expression in myometrium and uterine leiomyoma. Fertil Steril. 2002, 78:979-84. 10.1016\/s0015-0282(02)03366-6","journal-title":"Fertil Steril"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0303-7207(02)00230-7","article-title":"Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells","volume":"196","author":"Hodges LC","year":"2002","unstructured":"Hodges LC, Houston KD, Hunter DS, Fuchs-Young R, Zhang Z, Wineker RC, Walker CL. Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells. Mol Cell Endocrinol. 2002, 196:11-20. 10.1016\/s0303-7207(02)00230-7","journal-title":"Mol Cell Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000164","article-title":"Epidemiology of uterine fibroids: from menarche to menopause","volume":"59","author":"Wise LA","year":"2016","unstructured":"Wise LA, Laughlin-Tommaso SK. Epidemiology of uterine fibroids: from menarche to menopause. Clin Obstet Gynecol. 2016, 59:2-24. 10.1097\/GRF.0000000000000164","journal-title":"Clin Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.1.1","article-title":"Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking","volume":"153","author":"Faerstein E","year":"2001","unstructured":"Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol. 2001, 153:1-10. 10.1093\/aje\/153.1.1","journal-title":"Am J Epidemiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000154161.03418.e3","article-title":"Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study","volume":"105","author":"Wise LA","year":"2005","unstructured":"Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol. 2005, 105:563-8. 10.1097\/01.AOG.0000154161.03418.e3","journal-title":"Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.09.007","article-title":"Influence of vitamin D and transforming growth factor \u03b23 serum concentrations, obesity, and family history on the risk for uterine fibroids","volume":"106","author":"Ciebiera M","year":"2016","unstructured":"Ciebiera M, W\u0142odarczyk M, S\u0142abuszewska-J\u00f3\u017awiak A, Nowicka G, Jakiel G. Influence of vitamin D and transforming growth factor \u03b23 serum concentrations, obesity, and family history on the risk for uterine fibroids. Fertil Steril. 2016, 106:1787-92. 10.1016\/j.fertnstert.2016.09.007","journal-title":"Fertil Steril"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7575","article-title":"A case-control study of the relationship between visceral fat and development of uterine fibroids","volume":"18","author":"Sun K","year":"2019","unstructured":"Sun K, Xie Y, Zhao N, Li Z. A case-control study of the relationship between visceral fat and development of uterine fibroids. Exp Ther Med. 2019, 18:404-10. 10.3892\/etm.2019.7575","journal-title":"Exp Ther Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj363","article-title":"Association of physical activity with development of uterine leiomyoma","volume":"165","author":"Baird DD","year":"2007","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. Association of physical activity with development of uterine leiomyoma. Am J Epidemiol. 2007, 165:157-63. 10.1093\/aje\/kwj363","journal-title":"Am J Epidemiol"},{"key":"ref17","article-title":"Relationship between obesity and uterine leiomyomata","volume":"7","author":"Shikora SA","year":"1991","unstructured":"Shikora SA, Niloff JM, Bistrian BR, Forse RA, Blackburn GL. Relationship between obesity and uterine leiomyomata. Nutrition. 1991, 7:251-5.","journal-title":"Nutrition"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199607000-00018","article-title":"Reproductive factors and risk of uterine fibroids","volume":"7","author":"Parazzini F","year":"1996","unstructured":"Parazzini F, Negri E, La Vecchia C, Chatenoud L, Ricci E, Guarnerio P. Reproductive factors and risk of uterine fibroids. Epidemiology. 1996, 7:440-2. 10.1097\/00001648-199607000-00018","journal-title":"Epidemiology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird DD","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003, 188:100-7. 10.1067\/mob.2003.99","journal-title":"Am J Obstet Gynecol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2010.03.009","article-title":"The association between self-reported major life events and the presence of uterine fibroids","volume":"20","author":"Vines AI","year":"2010","unstructured":"Vines AI, Ta M, Esserman DA. The association between self-reported major life events and the presence of uterine fibroids. Womens Health Issues. 2010, 20:294-8. 10.1016\/j.whi.2010.03.009","journal-title":"Womens Health Issues"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0000000000000788","article-title":"Pervasive discrimination and allostatic load in African American and white adults","volume":"82","author":"Van Dyke ME","year":"2020","unstructured":"Van Dyke ME, Baumhofer NK, Slopen N, Mujahid MS, Clark CR, Williams DR, Lewis TT. Pervasive discrimination and allostatic load in African American and white adults. Psychosom Med. 2020, 82:316-23. 10.1097\/PSY.0000000000000788","journal-title":"Psychosom Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/76.1.187","article-title":"Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994","volume":"76","author":"Nesby-O'Dell S","year":"2002","unstructured":"Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al.. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002, 76:187-92. 10.1093\/ajcn\/76.1.187","journal-title":"Am J Clin Nutr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsgi.2005.10.007","article-title":"Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups","volume":"13","author":"Al-Hendy A","year":"2006","unstructured":"Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig. 2006, 13:136-44. 10.1016\/j.jsgi.2005.10.007","journal-title":"J Soc Gynecol Investig"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.04.037","article-title":"Polymorphisms in vitamin D-related genes and risk of uterine leiomyomata","volume":"102","author":"Wise LA","year":"2014","unstructured":"Wise LA, Ruiz-Narv\u00e1ez EA, Haddad SA, Rosenberg L, Palmer JR. Polymorphisms in vitamin D-related genes and risk of uterine leiomyomata. Fertil Steril. 2014, 102:503-10.e1. 10.1016\/j.fertnstert.2014.04.037","journal-title":"Fertil Steril"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/01.EDE.0000054360.61254.27","article-title":"Why is parity protective for uterine fibroids?","volume":"14","author":"Baird DD","year":"2003","unstructured":"Baird DD, Dunson DB. Why is parity protective for uterine fibroids?. Epidemiology. 2003, 14:247-50. 10.1097\/01.EDE.0000054360.61254.27","journal-title":"Epidemiology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.03.035","article-title":"Pregnancy-related fibroid reduction","volume":"94","author":"Laughlin SK","year":"2010","unstructured":"Laughlin SK, Herring AH, Savitz DA, Olshan AF, Fielding JR, Hartmann KE, Baird DD. Pregnancy-related fibroid reduction. Fertil Steril. 2010, 94:2421-3. 10.1016\/j.fertnstert.2010.03.035","journal-title":"Fertil Steril"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000114250","article-title":"Relationship between metabolic syndrome and uterine leiomyomas: a case-control study","volume":"66","author":"Takeda T","year":"2008","unstructured":"Takeda T, Sakata M, Isobe A, et al.. Relationship between metabolic syndrome and uterine leiomyomas: a case-control study. Gynecol Obstet Invest. 2008, 66:14-7. 10.1159\/000114250","journal-title":"Gynecol Obstet Invest"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi072","article-title":"A prospective study of hypertension and risk of uterine leiomyomata","volume":"161","author":"Boynton-Jarrett R","year":"2005","unstructured":"Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R. A prospective study of hypertension and risk of uterine leiomyomata. Am J Epidemiol. 2005, 161:628-38. 10.1093\/aje\/kwi072","journal-title":"Am J Epidemiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2174\/1566524019666191014170912","article-title":"Alcohol consumption and risk of uterine fibroids","volume":"20","author":"Takala H","year":"2020","unstructured":"Takala H, Yang Q, El Razek AM, Ali M, Al-Hendy A. Alcohol consumption and risk of uterine fibroids. Curr Mol Med. 2020, 20:247-58. 10.2174\/1566524019666191014170912","journal-title":"Curr Mol Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2015.11.023","article-title":"Cigarette smoking and risk of uterine myoma: systematic review and meta-analysis","volume":"197","author":"Chiaffarino F","year":"2016","unstructured":"Chiaffarino F, Ricci E, Cipriani S, Chiantera V, Parazzini F. Cigarette smoking and risk of uterine myoma: systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2016, 197:63-71. 10.1016\/j.ejogrb.2015.11.023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.08.074","article-title":"Risk factors for surgically removed fibroids in a large cohort of teachers","volume":"92","author":"Templeman C","year":"2009","unstructured":"Templeman C, Marshall SF, Clarke CA, et al.. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Steril. 2009, 92:1436-46. 10.1016\/j.fertnstert.2008.08.074","journal-title":"Fertil Steril"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.1408234","article-title":"Cadmium and proliferation in human uterine leiomyoma cells: evidence of a role for EGFR\/MAPK pathways but not classical estrogen receptor pathways","volume":"123","author":"Gao X","year":"2015","unstructured":"Gao X, Yu L, Moore AB, Kissling GE, Waalkes MP, Dixon D. Cadmium and proliferation in human uterine leiomyoma cells: evidence of a role for EGFR\/MAPK pathways but not classical estrogen receptor pathways. Environ Health Perspect. 2015, 123:331-6. 10.1289\/ehp.1408234","journal-title":"Environ Health Perspect"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e31828acca0","article-title":"Vitamin d and the risk of uterine fibroids","volume":"24","author":"Baird DD","year":"2013","unstructured":"Baird DD, Hill MC, Schectman JM, Hollis BW. Vitamin d and the risk of uterine fibroids. Epidemiology. 2013, 24:447-53. 10.1097\/EDE.0b013e31828acca0","journal-title":"Epidemiology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2015.05.013","article-title":"Vitamin D and uterine leiomyoma among a sample of US women: findings from NHANES, 2001-2006","volume":"57","author":"Mitro SD","year":"2015","unstructured":"Mitro SD, Zota AR. Vitamin D and uterine leiomyoma among a sample of US women: findings from NHANES, 2001-2006. Reprod Toxicol. 2015, 57:81-6. 10.1016\/j.reprotox.2015.05.013","journal-title":"Reprod Toxicol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1777","article-title":"Vitamin D status in women with uterine leiomyomas","volume":"98","author":"Paffoni A","year":"2013","unstructured":"Paffoni A, Somigliana E, Vigano' P, et al.. Vitamin D status in women with uterine leiomyomas. J Clin Endocrinol Metab. 2013, 98:E1374-8. 10.1210\/jc.2013-1777","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick MF","year":"2007","unstructured":"Holick MF. Vitamin D deficiency. N Engl J Med. 2007, 357:266-81. 10.1056\/NEJMra070553","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nux034","article-title":"Intestinal absorption of vitamin D: a systematic review","volume":"76","author":"Silva MC","year":"2018","unstructured":"Silva MC, Furlanetto TW. Intestinal absorption of vitamin D: a systematic review. Nutr Rev. 2018, 76:60-76. 10.1093\/nutrit\/nux034","journal-title":"Nutr Rev"},{"key":"ref38","article-title":"Vitamin D: Production, Metabolism, and Mechanism of Action","author":"Bikle DD","year":"2025","unstructured":"Bikle DD. Vitamin D: Production, Metabolism, and Mechanism of Action. Feingold KR, Adler RA, Ahmed SF, et al. (ed): Endotext, South Dartmouth, MA; 2025."},{"key":"ref39","article-title":"Vitamin D","author":"Jones G","year":"2014","unstructured":"Jones G. Vitamin D. Modern Nutrition in Health and Disease. Ross C, Caballero B, Cousins RJ, Tucker KL, Ziegler TR (ed): Lippincott Williams &amp; Wilkins, Philadelphia, PA; 2014. 278-92."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.17226\/13050","article-title":"","author":"Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium","year":"2011","unstructured":"Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Ross AC, Taylor CL, Yaktine AL, Del Valle HB (ed): National Academies Press, Washington, DC; 2011. 10.17226\/13050https:\/\/pubmed.ncbi.nlm.nih.gov\/21796828\/."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2450","article-title":"Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement","volume":"162","author":"LeFevre ML","year":"2015","unstructured":"LeFevre ML. Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015, 162:133-40. 10.7326\/M14-2450","journal-title":"Ann Intern Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2017.07.006","article-title":"Vitamin D metabolism in bariatric surgery","volume":"46","author":"Chakhtoura M","year":"2017","unstructured":"Chakhtoura M, Rahme M, El-Hajj Fuleihan G. Vitamin D metabolism in bariatric surgery. Endocrinol Metab Clin North Am. 2017, 46:947-82. 10.1016\/j.ecl.2017.07.006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e3282f4d2f3","article-title":"Vitamin D status in gastrointestinal and liver disease","volume":"24","author":"Pappa HM","year":"2008","unstructured":"Pappa HM, Bern E, Kamin D, Grand RJ. Vitamin D status in gastrointestinal and liver disease. Curr Opin Gastroenterol. 2008, 24:176-83. 10.1097\/MOG.0b013e3282f4d2f3","journal-title":"Curr Opin Gastroenterol"},{"key":"ref44","article-title":"Vitamin D deficiency in at-risk groups","volume":"86","author":"Patience S","year":"2013","unstructured":"Patience S. Vitamin D deficiency in at-risk groups. Community Pract. 2013, 86:38-40.","journal-title":"Community Pract"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082237","article-title":"Vitamin D synthesis following a single bout of sun exposure in older and younger men and women","volume":"12","author":"Chalcraft JR","year":"2020","unstructured":"Chalcraft JR, Cardinal LM, Wechsler PJ, et al.. Vitamin D synthesis following a single bout of sun exposure in older and younger men and women. Nutrients. 2020, 12:2237. 10.3390\/nu12082237","journal-title":"Nutrients"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.17789","article-title":"Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis","volume":"2","author":"Yao P","year":"2019","unstructured":"Yao P, Bennett D, Mafham M, Lin X, Chen Z, Armitage J, Clarke R. Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis. JAMA Netw Open. 2019, 2:e1917789. 10.1001\/jamanetworkopen.2019.17789","journal-title":"JAMA Netw Open"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1862","article-title":"Prevention of rickets and vitamin D deficiency in infants, children, and adolescents","volume":"122","author":"Wagner CL","year":"2008","unstructured":"Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008, 122:1142-52. 10.1542\/peds.2008-1862","journal-title":"Pediatrics"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2016.1021","article-title":"Vitamin D and chronic diseases","volume":"8","author":"Wang H","year":"2017","unstructured":"Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and chronic diseases. Aging Dis. 2017, 8:346-53. 10.14336\/AD.2016.1021","journal-title":"Aging Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520923492","article-title":"The associations between serum vitamin D, calcium and uterine fibroids in Chinese women: a case-controlled study","volume":"48","author":"Li S","year":"2020","unstructured":"Li S, Chen B, Sheng B, Wang J, Zhu X. The associations between serum vitamin D, calcium and uterine fibroids in Chinese women: a case-controlled study. J Int Med Res. 2020, 48:300060520923492. 10.1177\/0300060520923492","journal-title":"J Int Med Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-018-1195-4","article-title":"Vitamin D(3) level in women with uterine fibroid: an observational study in eastern Indian population","volume":"69","author":"Singh V","year":"2019","unstructured":"Singh V, Barik A, Imam N. Vitamin D(3) level in women with uterine fibroid: an observational study in eastern Indian population. J Obstet Gynaecol India. 2019, 69:161-5. 10.1007\/s13224-018-1195-4","journal-title":"J Obstet Gynaecol India"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-020-00644-6","article-title":"Correlation of low serum vitamin-D with uterine leiomyoma: a systematic review and meta-analysis","volume":"18","author":"Mohammadi R","year":"2020","unstructured":"Mohammadi R, Tabrizi R, Hessami K, Ashari H, Nowrouzi-Sohrabi P, Hosseini-Bensenjan M, Asadi N. Correlation of low serum vitamin-D with uterine leiomyoma: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2020, 18:85. 10.1186\/s12958-020-00644-6","journal-title":"Reprod Biol Endocrinol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1013192","article-title":"The association between vitamin D and uterine fibroids: a mendelian randomization study","volume":"13","author":"Guo W","year":"2022","unstructured":"Guo W, Dai M, Zhong Z, et al.. The association between vitamin D and uterine fibroids: a mendelian randomization study. Front Genet. 2022, 13:1013192. 10.3389\/fgene.2022.1013192","journal-title":"Front Genet"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine M","year":"2013","unstructured":"Mehine M, Kaasinen E, M\u00e4kinen N, et al.. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med. 2013, 369:43-53. 10.1056\/NEJMoa1302736","journal-title":"N Engl J Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171305","article-title":"MED12 mutation activates the tryptophan\/kynurenine\/AHR pathway to promote growth of uterine leiomyomas","volume":"8","author":"Zuberi A","year":"2023","unstructured":"Zuberi A, Huang Y, Dotts AJ, et al.. MED12 mutation activates the tryptophan\/kynurenine\/AHR pathway to promote growth of uterine leiomyomas. JCI Insight. 2023, 8:e171305. 10.1172\/jci.insight.171305","journal-title":"JCI Insight"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"M\u00e4kinen N","year":"2011","unstructured":"M\u00e4kinen N, Mehine M, Tolvanen J, et al.. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011, 334:252-5. 10.1126\/science.1208930","journal-title":"Science"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine M","year":"2016","unstructured":"Mehine M, Kaasinen E, Heinonen HR, et al.. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci U S A. 2016, 113:1315-20. 10.1073\/pnas.1518752113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-019-00084-7","article-title":"Introduction of somatic mutation in MED12 induces WNT4\/\u03b2-catenin and disrupts autophagy in human uterine myometrial cell","volume":"27","author":"El Andaloussi A","year":"2020","unstructured":"El Andaloussi A, Al-Hendy A, Ismail N, Boyer TG, Halder SK. Introduction of somatic mutation in MED12 induces WNT4\/\u03b2-catenin and disrupts autophagy in human uterine myometrial cell. Reprod Sci. 2020, 27:823-32. 10.1007\/s43032-019-00084-7","journal-title":"Reprod Sci"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.09.014","article-title":"Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities","volume":"111","author":"Asano R","year":"2019","unstructured":"Asano R, Asai-Sato M, Matsukuma S, et al.. Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities. Fertil Steril. 2019, 111:178-85. 10.1016\/j.fertnstert.2018.09.014","journal-title":"Fertil Steril"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01199-0","article-title":"Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas","volume":"7","author":"Heinonen HR","year":"2017","unstructured":"Heinonen HR, Pasanen A, Heikinheimo O, et al.. Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas. Sci Rep. 2017, 7:1015. 10.1038\/s41598-017-01199-0","journal-title":"Sci Rep"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00393","article-title":"On the complexity of mechanisms and consequences of chromothripsis: an update","volume":"10","author":"Koltsova AS","year":"2019","unstructured":"Koltsova AS, Pendina AA, Efimova OA, Chiryaeva OG, Kuznetzova TV, Baranov VS. On the complexity of mechanisms and consequences of chromothripsis: an update. Front Genet. 2019, 10:393. 10.3389\/fgene.2019.00393","journal-title":"Front Genet"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2004.08.025","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma","volume":"158","author":"Sandberg AA","year":"2005","unstructured":"Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma. Cancer Genet Cytogenet. 2005, 158:1-26. 10.1016\/j.cancergencyto.2004.08.025","journal-title":"Cancer Genet Cytogenet"},{"key":"ref62","doi-asserted-by":"crossref","DOI":"10.1002\/1098-2264(200007)28:3<235::AID-GCC1>3.0.CO;2-7","article-title":"Genetics of uterine leiomyomata","volume":"28","author":"Ligon AH","year":"2000","unstructured":"Ligon AH, Morton CC. Genetics of uterine leiomyomata. Genes Chromosomes Cancer. 2000, 28:235-45.","journal-title":"Genes Chromosomes Cancer"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2271","article-title":"Roles of HMGA proteins in cancer","volume":"7","author":"Fusco A","year":"2007","unstructured":"Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer. 2007, 7:899-910. 10.1038\/nrc2271","journal-title":"Nat Rev Cancer"},{"key":"ref64","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1098-2264(199812)23:4<279::AID-GCC1>3.0.CO;2-1","article-title":"HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors","volume":"23","author":"Kazmierczak B","year":"1998","unstructured":"Kazmierczak B, Dal Cin P, Wanschura S, Borrmann L, Fusco A, Van den Berghe H, Bullerdiek J. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer. 1998, 23:279-85.","journal-title":"Genes Chromosomes Cancer"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-4608(99)00054-0","article-title":"Expression of HMGIY in three uterine leiomyomata with complex rearrangements of chromosome 6","volume":"114","author":"Sornberger KS","year":"1999","unstructured":"Sornberger KS, Weremowicz S, Williams AJ, et al.. Expression of HMGIY in three uterine leiomyomata with complex rearrangements of chromosome 6. Cancer Genet Cytogenet. 1999, 114:9-16. 10.1016\/s0165-4608(99)00054-0","journal-title":"Cancer Genet Cytogenet"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-4608(99)00070-9","article-title":"hREC2, a RAD51-like gene, is disrupted by t(12;14)(q15;q24.1) in a uterine leiomyoma","volume":"115","author":"Ingraham SE","year":"1999","unstructured":"Ingraham SE, Lynch RA, Kathiresan S, Buckler AJ, Menon AG. hREC2, a RAD51-like gene, is disrupted by t(12;14)(q15;q24.1) in a uterine leiomyoma. Cancer Genet Cytogenet. 1999, 115:56-61. 10.1016\/s0165-4608(99)00070-9","journal-title":"Cancer Genet Cytogenet"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.08.018","article-title":"The RAD51 gene family, genetic instability and cancer","volume":"219","author":"Thacker J","year":"2005","unstructured":"Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett. 2005, 219:125-35. 10.1016\/j.canlet.2004.08.018","journal-title":"Cancer Lett"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/path.5920","article-title":"Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles","volume":"257","author":"Carbajo-Garc\u00eda MC","year":"2022","unstructured":"Carbajo-Garc\u00eda MC, Corach\u00e1n A, Ju\u00e1rez-Barber E, et al.. Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles. J Pathol. 2022, 257:663-73. 10.1002\/path.5920","journal-title":"J Pathol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-5122(00)00160-2","article-title":"Heritability and risk factors of uterine fibroids--the Finnish Twin Cohort study","volume":"37","author":"Luoto R","year":"2000","unstructured":"Luoto R, Kaprio J, Rutanen EM, Taipale P, Perola M, Koskenvuo M. Heritability and risk factors of uterine fibroids--the Finnish Twin Cohort study. Maturitas. 2000, 37:15-26. 10.1016\/s0378-5122(00)00160-2","journal-title":"Maturitas"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1126\/science.150.3692.67","article-title":"Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas","volume":"150","author":"Linder D","year":"1965","unstructured":"Linder D, Gartler SM. Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science. 1965, 150:67-9. 10.1126\/science.150.3692.67","journal-title":"Science"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0704472104","article-title":"Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells","volume":"104","author":"Ono M","year":"2007","unstructured":"Ono M, Maruyama T, Masuda H, et al.. Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells. Proc Natl Acad Sci U S A. 2007, 104:18700-5. 10.1073\/pnas.0704472104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.04.044","article-title":"Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells","volume":"98","author":"Mas A","year":"2012","unstructured":"Mas A, Cervell\u00f3 I, Gil-Sanchis C, Faus A, Ferro J, Pellicer A, Sim\u00f3n C. Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells. Fertil Steril. 2012, 98:741-51.e6. 10.1016\/j.fertnstert.2012.04.044","journal-title":"Fertil Steril"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1038\/srep39931","article-title":"Effects of elevated \u03b2-estradiol levels on the functional morphology of the testis - new insights","volume":"7","author":"Leavy M","year":"2017","unstructured":"Leavy M, Trottmann M, Liedl B, et al.. Effects of elevated \u03b2-estradiol levels on the functional morphology of the testis - new insights. Sci Rep. 2017, 7:39931. 10.1038\/srep39931","journal-title":"Sci Rep"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2012.09.005","article-title":"Integrin \u03b21 regulates leiomyoma cytoskeletal integrity and growth","volume":"31","author":"Malik M","year":"2012","unstructured":"Malik M, Segars J, Catherino WH. Integrin \u03b21 regulates leiomyoma cytoskeletal integrity and growth. Matrix Biol. 2012, 31:389-97. 10.1016\/j.matbio.2012.09.005","journal-title":"Matrix Biol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics","volume":"24","author":"Islam MS","year":"2018","unstructured":"Islam MS, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018, 24:59-85. 10.1093\/humupd\/dmx032","journal-title":"Hum Reprod Update"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2012.04.046","article-title":"Are uterine leiomyoma a consequence of a chronically inflammatory immune system?","volume":"79","author":"Wegienka G","year":"2012","unstructured":"Wegienka G. Are uterine leiomyoma a consequence of a chronically inflammatory immune system?. Med Hypotheses. 2012, 79:226-31. 10.1016\/j.mehy.2012.04.046","journal-title":"Med Hypotheses"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.982246","article-title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","volume":"31","author":"Singh SS","year":"2015","unstructured":"Singh SS, Belland L. Contemporary management of uterine fibroids: focus on emerging medical treatments. Curr Med Res Opin. 2015, 31:1-12. 10.1185\/03007995.2014.982246","journal-title":"Curr Med Res Opin"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.121725","article-title":"Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas","volume":"186","author":"Dueholm M","year":"2002","unstructured":"Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002, 186:409-15. 10.1067\/mob.2002.121725","journal-title":"Am J Obstet Gynecol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1007\/s10916-023-01947-y","article-title":"Three-dimensional volume rendering of pelvic floor anatomy with focus on fibroids in relation to the lower urogenital tract based on cross-sectional MRI images","volume":"47","author":"Fan KS","year":"2023","unstructured":"Fan KS, Durnea C, Nygaard CC, Khalil M, Doumouchtsis SK. Three-dimensional volume rendering of pelvic floor anatomy with focus on fibroids in relation to the lower urogenital tract based on cross-sectional MRI images. J Med Syst. 2023, 47:62. 10.1007\/s10916-023-01947-y","journal-title":"J Med Syst"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(15)30338-8","article-title":"The management of uterine leiomyomas","volume":"37","author":"Vilos GA","year":"2015","unstructured":"Vilos GA, Allaire C, Laberge PY, Leyland N. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015, 37:157-78. 10.1016\/S1701-2163(15)30338-8","journal-title":"J Obstet Gynaecol Can"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004557","article-title":"ACOG Practice Bulletin No. 228: management of symptomatic uterine leiomyomas: correction","volume":"138","year":"2021","unstructured":"ACOG Practice Bulletin No. 228. management of symptomatic uterine leiomyomas: correction. Obstet Gynecol. 2021, 138:683. 10.1097\/AOG.0000000000004557","journal-title":"Obstet Gynecol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003677.pub5","article-title":"Surgical approach to hysterectomy for benign gynaecological disease","volume":"2015","author":"Aarts JW","year":"2015","unstructured":"Aarts JW, Nieboer TE, Johnson N, Tavender E, Garry R, Mol BW, Kluivers KB. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015, 2015:CD003677. 10.1002\/14651858.CD003677.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-014-3228-2","article-title":"Randomized comparison of total laparoscopic, laparoscopically assisted vaginal and vaginal hysterectomies for myomatous uteri","volume":"290","author":"Sesti F","year":"2014","unstructured":"Sesti F, Cosi V, Calonzi F, Ruggeri V, Pietropolli A, Di Francesco L, Piccione E. Randomized comparison of total laparoscopic, laparoscopically assisted vaginal and vaginal hysterectomies for myomatous uteri. Arch Gynecol Obstet. 2014, 290:485-91. 10.1007\/s00404-014-3228-2","journal-title":"Arch Gynecol Obstet"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2002.811206.x","article-title":"Comparative study of vaginal, laparoscopically assisted vaginal and abdominal hysterectomies for uterine myoma larger than 6 cm in diameter or uterus weighing at least 450 g: a prospective randomized study","volume":"81","author":"Hwang JL","year":"2002","unstructured":"Hwang JL, Seow KM, Tsai YL, Huang LW, Hsieh BC, Lee C. Comparative study of vaginal, laparoscopically assisted vaginal and abdominal hysterectomies for uterine myoma larger than 6 cm in diameter or uterus weighing at least 450 g: a prospective randomized study. Acta Obstet Gynecol Scand. 2002, 81:1132-8. 10.1034\/j.1600-0412.2002.811206.x","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.08.047","article-title":"Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation","volume":"214","author":"Harris JA","year":"2016","unstructured":"Harris JA, Swenson CW, Uppal S, Kamdar N, Mahnert N, As-Sanie S, Morgan DM. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation. Am J Obstet Gynecol. 2016, 214:98.e1-e13. 10.1016\/j.ajog.2015.08.047","journal-title":"Am J Obstet Gynecol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004507","article-title":"Uterine morcellation for presumed leiomyomas: ACOG Committee Opinion, Number 822: correction","volume":"138","year":"2021","unstructured":"Uterine morcellation for presumed leiomyomas. ACOG Committee Opinion, Number 822: correction. Obstet Gynecol. 2021, 138:313. 10.1097\/AOG.0000000000004507","journal-title":"Obstet Gynecol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004638","article-title":"Minimally invasive surgical techniques versus open myomectomy for uterine fibroids","volume":"2014","author":"Chittawar PB","year":"2014","unstructured":"Chittawar PB, Franik S, Pouwer AW, Farquhar C. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014, 2014:CD004638. 10.1002\/14651858.CD004638","journal-title":"Cochrane Database Syst Rev"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2009.10.013","article-title":"Hysteroscopic management of large symptomatic submucous uterine myomas","volume":"17","author":"Camanni M","year":"2010","unstructured":"Camanni M, Bonino L, Delpiano EM, Ferrero B, Migliaretti G, Deltetto F. Hysteroscopic management of large symptomatic submucous uterine myomas. J Minim Invasive Gynecol. 2010, 17:59-65. 10.1016\/j.jmig.2009.10.013","journal-title":"J Minim Invasive Gynecol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez J","year":"2016","unstructured":"Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016, 22:665-86. 10.1093\/humupd\/dmw023","journal-title":"Hum Reprod Update"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005073.pub2","article-title":"Uterine artery embolization for symptomatic uterine fibroids","author":"Gupta JK","year":"2006","unstructured":"Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2006, CD005073. 10.1002\/14651858.CD005073.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000275283.39475.f6","article-title":"Sustained relief of leiomyoma symptoms by using focused ultrasound surgery","volume":"110","author":"Stewart EA","year":"2007","unstructured":"Stewart EA, Gostout B, Rabinovici J, Kim HS, Regan L, Tempany CM. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007, 110:279-87. 10.1097\/01.AOG.0000275283.39475.f6","journal-title":"Obstet Gynecol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.10.001","article-title":"Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids","volume":"93","author":"Rabinovici J","year":"2010","unstructured":"Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010, 93:199-209. 10.1016\/j.fertnstert.2008.10.001","journal-title":"Fertil Steril"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2018.61.2.192","article-title":"Current medical treatment of uterine fibroids","volume":"61","author":"Sohn GS","year":"2018","unstructured":"Sohn GS, Cho S, Kim YM, Cho CH, Kim MR, Lee SR. Current medical treatment of uterine fibroids. Obstet Gynecol Sci. 2018, 61:192-201. 10.5468\/ogs.2018.61.2.192","journal-title":"Obstet Gynecol Sci"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed GH","year":"2011","unstructured":"Sayed GH, Zakherah MS, El-Nashar SA, Shaaban MM. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia. Int J Gynaecol Obstet. 2011, 112:126-30. 10.1016\/j.ijgo.2010.08.009","journal-title":"Int J Gynaecol Obstet"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.02.011","article-title":"Intrauterine device use among women with uterine fibroids: a systematic review","volume":"82","author":"Zapata LB","year":"2010","unstructured":"Zapata LB, Whiteman MK, Tepper NK, Jamieson DJ, Marchbanks PA, Curtis KM. Intrauterine device use among women with uterine fibroids: a systematic review. Contraception. 2010, 82:41-55. 10.1016\/j.contraception.2010.02.011","journal-title":"Contraception"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000249","article-title":"Antifibrinolytics for heavy menstrual bleeding","author":"Lethaby A","year":"2000","unstructured":"Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000, CD000249. 10.1002\/14651858.CD000249","journal-title":"Cochrane Database Syst Rev"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318032125e","article-title":"Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas","volume":"31","author":"Ip PP","year":"2007","unstructured":"Ip PP, Lam KW, Cheung CL, Yeung MC, Pun TC, Chan QK, Cheung AN. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas. Am J Surg Pathol. 2007, 31:1215-24. 10.1097\/PAS.0b013e318032125e","journal-title":"Am J Surg Pathol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(11)90533-x","article-title":"A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia","volume":"164","author":"Milsom I","year":"1991","unstructured":"Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol. 1991, 164:879-83. 10.1016\/s0002-9378(11)90533-x","journal-title":"Am J Obstet Gynecol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2002.01225.x","article-title":"Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review","volume":"109","author":"Lethaby A","year":"2002","unstructured":"Lethaby A, Vollenhoven B, Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. BJOG. 2002, 109:1097-108. 10.1111\/j.1471-0528.2002.01225.x","journal-title":"BJOG"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez J","year":"2012","unstructured":"Donnez J, Tatarchuk TF, Bouchard P, et al.. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012, 366:409-20. 10.1056\/NEJMoa1103182","journal-title":"N Engl J Med"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009505.pub2","article-title":"Aromatase inhibitors for uterine fibroids","volume":"2013","author":"Song H","year":"2013","unstructured":"Song H, Lu D, Navaratnam K, Shi G. Aromatase inhibitors for uterine fibroids. Cochrane Database Syst Rev. 2013, 2013:CD009505. 10.1002\/14651858.CD009505.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.5402\/2013\/898125","article-title":"The pleiotropic effect of vitamin d","volume":"2013","author":"Lai YH","year":"2013","unstructured":"Lai YH, Fang TC. The pleiotropic effect of vitamin d. ISRN Nephrol. 2013, 2013:898125. 10.5402\/2013\/898125","journal-title":"ISRN Nephrol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020597","article-title":"Vitamin D: mechanism of action and biological effects in uterine fibroids","volume":"13","author":"Vergara D","year":"2021","unstructured":"Vergara D, Catherino WH, Trojano G, Tinelli A. Vitamin D: mechanism of action and biological effects in uterine fibroids. Nutrients. 2021, 13:597. 10.3390\/nu13020597","journal-title":"Nutrients"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2018.08.018","article-title":"Human uterine leiomyoma contains low levels of 1, 25 dihdroxyvitamin D3, and shows dysregulated expression of vitamin D metabolizing enzymes","volume":"229","author":"Othman ER","year":"2018","unstructured":"Othman ER, Ahmed E, Sayed AA, et al.. Human uterine leiomyoma contains low levels of 1, 25 dihdroxyvitamin D3, and shows dysregulated expression of vitamin D metabolizing enzymes. Eur J Obstet Gynecol Reprod Biol. 2018, 229:117-22. 10.1016\/j.ejogrb.2018.08.018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.02.136","article-title":"Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro","volume":"91","author":"Bl\u00e4uer M","year":"2009","unstructured":"Bl\u00e4uer M, Rovio PH, Ylikomi T, Heinonen PK. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil Steril. 2009, 91:1919-25. 10.1016\/j.fertnstert.2008.02.136","journal-title":"Fertil Steril"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.07.1041","article-title":"Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase","volume":"95","author":"Sharan C","year":"2011","unstructured":"Sharan C, Halder SK, Thota C, Jaleel T, Nair S, Al-Hendy A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril. 2011, 95:247-53. 10.1016\/j.fertnstert.2010.07.1041","journal-title":"Fertil Steril"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2015.11.015","article-title":"Hormones and pathogenesis of uterine fibroids","volume":"34","author":"Reis FM","year":"2016","unstructured":"Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016, 34:13-24. 10.1016\/j.bpobgyn.2015.11.015","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1615015114","article-title":"Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells","volume":"114","author":"Tavera-Mendoza LE","year":"2017","unstructured":"Tavera-Mendoza LE, Westerling T, Libby E, et al.. Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells. Proc Natl Acad Sci U S A. 2017, 114:E2186-94. 10.1073\/pnas.1615015114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.11.027","article-title":"Vitamin D regulates contractile profile in human uterine myometrial cells via NF-\u03baB pathway","volume":"210","author":"Thota C","year":"2014","unstructured":"Thota C, Laknaur A, Farmer T, Ladson G, Al-Hendy A, Ismail N. Vitamin D regulates contractile profile in human uterine myometrial cells via NF-\u03baB pathway. Am J Obstet Gynecol. 2014, 210:347.e1-e10. 10.1016\/j.ajog.2013.11.027","journal-title":"Am J Obstet Gynecol"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1313650110","article-title":"Paracrine activation of WNT\/\u03b2-catenin pathway in uterine leiomyoma stem cells promotes tumor growth","volume":"110","author":"Ono M","year":"2013","unstructured":"Ono M, Yin P, Navarro A, et al.. Paracrine activation of WNT\/\u03b2-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc Natl Acad Sci U S A. 2013, 110:17053-8. 10.1073\/pnas.1313650110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.10.008","article-title":"Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt\/\u03b2-catenin pathway","volume":"111","author":"Corach\u00e1n A","year":"2019","unstructured":"Corach\u00e1n A, Ferrero H, Aguilar A, et al.. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt\/\u03b2-catenin pathway. Fertil Steril. 2019, 111:397-407. 10.1016\/j.fertnstert.2018.10.008","journal-title":"Fertil Steril"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.07.049","article-title":"Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation","volume":"115","author":"Corach\u00e1n A","year":"2021","unstructured":"Corach\u00e1n A, Trejo MG, Carbajo-Garc\u00eda MC, et al.. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation. Fertil Steril. 2021, 115:512-21. 10.1016\/j.fertnstert.2020.07.049","journal-title":"Fertil Steril"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det265","article-title":"Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells","volume":"28","author":"Halder SK","year":"2013","unstructured":"Halder SK, Osteen KG, Al-Hendy A. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013, 28:2407-16. 10.1093\/humrep\/det265","journal-title":"Hum Reprod"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-018-0184-6","article-title":"Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment","volume":"40","author":"Ali M","year":"2019","unstructured":"Ali M, Shahin SM, Sabri NA, Al-Hendy A, Yang Q. Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment. Acta Pharmacol Sin. 2019, 40:957-70. 10.1038\/s41401-018-0184-6","journal-title":"Acta Pharmacol Sin"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061459","article-title":"Vitamin D3 ameliorates DNA damage caused by developmental exposure to endocrine disruptors in the uterine myometrial stem cells of Eker rats","volume":"9","author":"Elkafas H","year":"2020","unstructured":"Elkafas H, Ali M, Elmorsy E, et al.. Vitamin D3 ameliorates DNA damage caused by developmental exposure to endocrine disruptors in the uterine myometrial stem cells of Eker rats. Cells. 2020, 9:1459. 10.3390\/cells9061459","journal-title":"Cells"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S163961","article-title":"Diet-induced vitamin D deficiency triggers inflammation and DNA damage profile in murine myometrium","volume":"10","author":"Elhusseini H","year":"2018","unstructured":"Elhusseini H, Elkafas H, Abdelaziz M, et al.. Diet-induced vitamin D deficiency triggers inflammation and DNA damage profile in murine myometrium. Int J Womens Health. 2018, 10:503-14. 10.2147\/IJWH.S163961","journal-title":"Int J Womens Health"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.111.098145","article-title":"1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model","volume":"86","author":"Halder SK","year":"2012","unstructured":"Halder SK, Sharan C, Al-Hendy A. 1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod. 2012, 86:116. 10.1095\/biolreprod.111.098145","journal-title":"Biol Reprod"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2012.06.004","article-title":"The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload","volume":"132","author":"Meems LM","year":"2012","unstructured":"Meems LM, Cannon MV, Mahmud H, et al.. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. J Steroid Biochem Mol Biol. 2012, 132:282-9. 10.1016\/j.jsbmb.2012.06.004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.09.018","article-title":"Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model","volume":"113","author":"Corach\u00e1n A","year":"2020","unstructured":"Corach\u00e1n A, Ferrero H, Escrig J, Monleon J, Faus A, Cervell\u00f3 I, Pellicer A. Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model. Fertil Steril. 2020, 113:205-216.e4. 10.1016\/j.fertnstert.2019.09.018","journal-title":"Fertil Steril"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005698","article-title":"Hypovitaminosis D and \"small burden\" uterine fibroids: opportunity for a vitamin D supplementation","volume":"95","author":"Ciavattini A","year":"2016","unstructured":"Ciavattini A, Delli Carpini G, Serri M, et al.. Hypovitaminosis D and \"small burden\" uterine fibroids: opportunity for a vitamin D supplementation. Medicine (Baltimore). 2016, 95:e5698. 10.1097\/MD.0000000000005698","journal-title":"Medicine (Baltimore)"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.10.2.125","article-title":"The effect of vitamin D supplementation on the size of uterine leiomyoma in women with vitamin D deficiency","volume":"10","author":"Hajhashemi M","year":"2019","unstructured":"Hajhashemi M, Ansari M, Haghollahi F, Eslami B. The effect of vitamin D supplementation on the size of uterine leiomyoma in women with vitamin D deficiency. Caspian J Intern Med. 2019, 10:125-31. 10.22088\/cjim.10.2.125","journal-title":"Caspian J Intern Med"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2020.101159","article-title":"Effect of oral consumption of vitamin D on uterine fibroids: a randomized clinical trial","volume":"39","author":"Arjeh S","year":"2020","unstructured":"Arjeh S, Darsareh F, Asl ZA, Azizi Kutenaei M. Effect of oral consumption of vitamin D on uterine fibroids: a randomized clinical trial. Complement Ther Clin Pract. 2020, 39:101159. 10.1016\/j.ctcp.2020.101159","journal-title":"Complement Ther Clin Pract"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1550062","article-title":"Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy - 2 case studies","volume":"35","author":"Ciebiera M","year":"2019","unstructured":"Ciebiera M, M\u0119czekalski B, \u0141ukaszuk K, Jakiel G. Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy - 2 case studies. Gynecol Endocrinol. 2019, 35:473-7. 10.1080\/09513590.2018.1550062","journal-title":"Gynecol Endocrinol"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202003_20702","article-title":"Vitamin D plus epigallocatechin gallate: a novel promising approach for uterine myomas","volume":"24","author":"Porcaro G","year":"2020","unstructured":"Porcaro G, Santamaria A, Giordano D, Angelozzi P. Vitamin D plus epigallocatechin gallate: a novel promising approach for uterine myomas. Eur Rev Med Pharmacol Sci. 2020, 24:3344-51. 10.26355\/eurrev_202003_20702","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.70271","article-title":"Effect of low-dose vitamin D supplementation on uterine fibroid size in women with hypovitaminosis D: a nonrandomized pilot study","volume":"171","author":"Orive A","year":"2025","unstructured":"Orive A, Corach\u00e1n A, Escrig J, Mascarell-L\u00f3pez MD, Pellicer A, Monle\u00f3n J, Ferrero H. Effect of low-dose vitamin D supplementation on uterine fibroid size in women with hypovitaminosis D: a nonrandomized pilot study. Int J Gynaecol Obstet. 2025, 171:720-7. 10.1002\/ijgo.70271","journal-title":"Int J Gynaecol Obstet"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2024.102632","article-title":"The association of vitamin D with uterine fibroids in premenopausal patients: a systematic review and meta-analysis","volume":"46","author":"Ivanova M","year":"2024","unstructured":"Ivanova M, Soule A, Pudwell J, Bougie O. The association of vitamin D with uterine fibroids in premenopausal patients: a systematic review and meta-analysis. J Obstet Gynaecol Can. 2024, 46:102632. 10.1016\/j.jogc.2024.102632","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/511797-influence-of-vitamin-d-on-the-growth-and-development-of-uterine-fibroids","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:07:44Z","timestamp":1786475264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/511797-influence-of-vitamin-d-on-the-growth-and-development-of-uterine-fibroids"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":126,"URL":"https:\/\/doi.org\/10.7759\/cureus.114365","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}